185 related articles for article (PubMed ID: 20553141)
41. Biochemical activities of extracts from Hypericum perforatum L. 1st Communication: inhibition of dopamine-beta-hydroxylase.
Kleber E; Obry T; Hippeli S; Schneider W; Elstner EF
Arzneimittelforschung; 1999 Feb; 49(2):106-9. PubMed ID: 10083977
[TBL] [Abstract][Full Text] [Related]
42. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
43. Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John's wort.
Wielgus AR; Chignell CF; Miller DS; Van Houten B; Meyer J; Hu DN; Roberts JE
Photochem Photobiol; 2007; 83(3):706-13. PubMed ID: 17576381
[TBL] [Abstract][Full Text] [Related]
44. Identification of human intracellular targets of the medicinal Herb St. John's Wort by chemical-genetic profiling in yeast.
McCue PP; Phang JM
J Agric Food Chem; 2008 Nov; 56(22):11011-7. PubMed ID: 18975972
[TBL] [Abstract][Full Text] [Related]
45. St. John's wort relieves pain in an animal model of migraine.
Galeotti N; Ghelardini C
Eur J Pain; 2013 Mar; 17(3):369-81. PubMed ID: 23152076
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the in vitro inhibitory impact of hypericin on placental glutathione S-transferase pi.
Dalmizrak O; Kulaksiz-Erkmen G; Ozer N
Protein J; 2012 Oct; 31(7):544-9. PubMed ID: 22810152
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
Jackson A; D'Avolio A; Moyle G; Bonora S; Di Perri G; Else L; Simiele M; Singh GJ; Back D; Boffito M
J Antimicrob Chemother; 2014 Jul; 69(7):1911-5. PubMed ID: 24610312
[TBL] [Abstract][Full Text] [Related]
48. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure.
Perloff MD; von Moltke LL; Störmer E; Shader RI; Greenblatt DJ
Br J Pharmacol; 2001 Dec; 134(8):1601-8. PubMed ID: 11739235
[TBL] [Abstract][Full Text] [Related]
49. Hypericin, a medicinal compound from St. John's Wort, inhibits genotoxicity induced by mutagenic agents in V79 cells.
de Souza LM; de Sousa FD; Cruz RCR; Tavares DC; Francielli de Oliveira P
Drug Chem Toxicol; 2022 May; 45(3):1302-1307. PubMed ID: 33050761
[TBL] [Abstract][Full Text] [Related]
50. Jasmonic acid-induced hypericin production in cell suspension cultures of Hypericum perforatum L. (St. John's wort).
Walker TS; Pal Bais H; Vivanco JM
Phytochemistry; 2002 Jun; 60(3):289-93. PubMed ID: 12031448
[TBL] [Abstract][Full Text] [Related]
51. St. John's wort significantly increased the systemic exposure and toxicity of methotrexate in rats.
Yang SY; Juang SH; Tsai SY; Chao PD; Hou YC
Toxicol Appl Pharmacol; 2012 Aug; 263(1):39-43. PubMed ID: 22699020
[TBL] [Abstract][Full Text] [Related]
52. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding.
Raffa RB
Life Sci; 1998; 62(16):PL265-70. PubMed ID: 9585174
[TBL] [Abstract][Full Text] [Related]
53. Effects of St John's wort and hypericin on cytotoxicity of anticancer drugs.
Wada A; Sakaeda T; Takara K; Hirai M; Kimura T; Ohmoto N; Zhou J; Nakamura T; Kobayashi H; Okamura N; Yagami T; Okumura K
Drug Metab Pharmacokinet; 2002; 17(5):467-74. PubMed ID: 15618698
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment.
Butterweck V; Korte B; Winterhoff H
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S2-7. PubMed ID: 11518068
[TBL] [Abstract][Full Text] [Related]
55. Cytological and biochemical effects of St. John's Wort supplement (a complex mixture of St. John's Wort, Rosemary and Spirulina) on somatic and germ cells of Swiss Albino mice.
Aleisa AM
Int J Environ Res Public Health; 2008 Dec; 5(5):408-17. PubMed ID: 19151436
[TBL] [Abstract][Full Text] [Related]
56. St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.
Ott M; Huls M; Cornelius MG; Fricker G
Pharm Res; 2010 May; 27(5):811-22. PubMed ID: 20229133
[TBL] [Abstract][Full Text] [Related]
57. Effects of rifampicin, dexamethasone, St. John's Wort and Thyroxine on maternal and foetal expression of Abcb1 and organ distribution of talinolol in pregnant rats.
Saljé K; Lederer K; Oswald S; Dazert E; Warzok R; Siegmund W
Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):99-105. PubMed ID: 22339773
[TBL] [Abstract][Full Text] [Related]
58. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
59. A high-performance liquid chromatography with electrochemical detection for the determination of total hypericin in extracts of St. John's Wort.
Rückert U; Eggenreich K; Likussar W; Wintersteiger R; Michelitsch A
Phytochem Anal; 2006; 17(3):162-7. PubMed ID: 16749423
[TBL] [Abstract][Full Text] [Related]
60. Dissolution, solubility and cooperativity of phenolic compounds from Hypericum perforatum L. in aqueous systems.
Jürgenliemk G; Nahrstedt A
Pharmazie; 2003 Mar; 58(3):200-3. PubMed ID: 12685814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
